Researcher.Life Logo

ClinicoEconomics and Outcomes Research : Impact Factor & More

eISSN: 1178-6981pISSN: 1178-6981
JournalOpen Access

Key Metrics

CiteScore
2.5
SJR
Q2Health Policy
SNIP
0.74
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ClinicoEconomics and Outcomes Research

ClinicoEconomics and Outcomes Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2390
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in ClinicoEconomics and Outcomes Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ClinicoEconomics and Outcomes Research

Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
  • 9 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Research Gaps and Priorities for aHUS in the Gulf Cooperation Countries (GCC): Findings from a Payer-Focused Expert Meeting.
  • 1 May 2026
  • ClinicoEconomics and outcomes research : CEOR
Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy
  • 9 Apr 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experience
  • 3 Apr 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy
  • 1 Apr 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa.
  • 1 Apr 2026
  • ClinicoEconomics and outcomes research : CEOR
Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy
  • 9 May 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Research Gaps and Priorities for aHUS in the Gulf Cooperation Countries (GCC): Findings from a Payer-Focused Expert Meeting.
  • 1 May 2026
  • ClinicoEconomics and outcomes research : CEOR
Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy
  • 9 Apr 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experience
  • 3 Apr 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italy
  • 1 Apr 2026
  • ClinicoEconomics and Outcomes Research: CEOR
Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosa.
  • 1 Apr 2026
  • ClinicoEconomics and outcomes research : CEOR

FAQs on ClinicoEconomics and Outcomes Research